Cargando…
Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
BACKGROUND: Though the associations between low serum 25-hydroxyvitamin D (25(OH)D) levels and health outcomes such as type 2 diabetes (T2D), myocardial infarction (MI), cancer, and mortality are well-studied, the effect of supplementation with vitamin D is uncertain. This may be related to genetic...
Autores principales: | Zostautiene, Ieva, Jorde, Rolf, Schirmer, Henrik, Mathiesen, Ellisiv Bøgeberg, Njølstad, Inger, Løchen, Maja-Lisa, Wilsgaard, Tom, Joakimsen, Ragnar Martin, Kamycheva, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689352/ https://www.ncbi.nlm.nih.gov/pubmed/26699871 http://dx.doi.org/10.1371/journal.pone.0145359 |
Ejemplares similares
-
Correction: Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
por: Martinaityte, Ieva, et al.
Publicado: (2016) -
The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study
por: Jorde, Rolf, et al.
Publicado: (2015) -
Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø Study
por: Jorde, Rolf, et al.
Publicado: (2012) -
Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2015) -
Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012
por: Carlsson, Maria, et al.
Publicado: (2016)